This book is intended to help newly graduated chemists, particularly organic chemists, at all levels from bachelors to post-doctorates, find careers in the North American pharmaceutical industry. It will serve as a practical, detailed guiedbook for job seekers as well a referenc…
"353" Result
Sort By:
This book is intended to help newly graduated chemists, particularly organic chemists, at all levels from bachelors to post-doctorates, find careers in the North American pharmaceutical industry. It will serve as a practical, detailed guiedbook for job seekers as well a referenc…
Towards drugs of the future: key issues in lead finding and lead optimization
by Solvay Pharmaceuticals Conference on Medicinal Chemistry, Garmisch-Partenkirchen, Germany), Kruse, C. G., (Chris G.), Timmerman, H., (Hendrick), Solvay Pharmaceuticals
fromSolvay Pharmaceuticals Conferences
0
Type: Book
The number of novel medications in the global industry pipeline is insufficient to suffice demand of the markets, the financial performance of several companies is declining, and sales and marketing costs are rising. This title addresses the development in synthetic and medicina…
Statistical Thinking for Non-Statisticians in Drug Regulation, Second Edition, is a need-to-know guide to understanding statistical methodology, statistical data and results within drug development and clinical trials. It provides non-statisticians working in the pharmaceutical …
Statistical Thinking for Non-Statisticians in Drug Regulation, Second Edition, is a need-to-know guide to understanding statistical methodology, statistical data and results within drug development and clinical trials. It provides non-statisticians working in the pharmaceutical …
Statistical Thinking for Non-Statisticians in Drug Regulation, Second Edition, is a need-to-know guide to understanding statistical methodology, statistical data and results within drug development and clinical trials. It provides non-statisticians working in the pharmaceutical …
Statistical Thinking for Non-Statisticians in Drug Regulation, Second Edition, is a need-to-know guide to understanding statistical methodology, statistical data and results within drug development and clinical trials. It provides non-statisticians working in the pharmaceutical …
From Abilify to Zyrtec and nearly every drug in between, Mosby's Drug Reference for Health Professions, 4th Edition is the must-have portable drug handbook for every current or aspiring health professional in the field today.
From Abilify to Zyrtec and nearly every drug in between, Mosby's Drug Reference for Health Professions, 4th Edition is the must-have portable drug handbook for every current or aspiring health professional in the field today. This updated edition features concise, reliable infor…
This publication, known as the "Orange Guide", has been an essential reference for those involved in the manufacture or distribution of medicines in Europe. The Orange Guide collates in one convenient and authoritative source European and UK guidance documents and information on…
"The pharmaceutical industry is one of the most important industries in the world, offering new medicines, vaccines, and cures to a global population. It is a massive industry, worthy of a deep and thorough examination of its processes and chemistry, with a view toward sustainab…
This is the second volume in a four-volume series aimed at guiding the pharmaceutical industry toward sustainability. After analyzing and exposing some of the backward and ill-conceived notions that guide the present state of the industry, this volume presents key theories and n…
Intro -- Missing data -- Where do new drugs come from? -- Bad regulators -- Bad trials -- Bigger, simpler trials -- Marketing -- Afterword: better data.
